V9 Anti-Human α4β7 (Vedolizumab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
α4β7
Purification
IEC
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human IgG1 (L235A/G237A/E356D/M358L) -Kappa
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2074427-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Solute Carrier Family 3, Member 2 (SLC3A2)
Sign In for Pricing
View Details 
MBS2074427-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Solute Carrier Family 3, Member 2 (SLC3A2)
Sign In for Pricing
View Details MBS2074427-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Solute Carrier Family 3, Member 2 (SLC3A2)
Sign In for Pricing
View Details